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introDuction
In late December 2019, the 2019 novel coronavirus pneu-
monia caused by severe acute respiratory syndrome coro-
navirus 2 (SARS- CoV-2) occurred in Wuhan, China, and 
has spread quickly worldwide. During the first two decades 
of the 21st century, there have been three coronavirus 
infection outbreaks raising global health concerns by the 
SARS- CoV, the Middle East respiratory syndrome corona-
virus (MERS- CoV), and the SARS- CoV-2 (the respiratory 
disease caused by SARS- CoV-2 is now called coronavirus 
disease-19, COVID-19). Coronaviruses are enveloped 
viruses with a positive- sense single- stranded RNA genome 
and have club- shaped surface- spike glycoprotein which 
plays an important role in binding to receptors on host cells. 
After the virus enters the cells, its antigen is presented to 
dendritic cell or macrophage, which stimulates the body’s 
humoral and cellular immunity (Figure  1). Coronavirus 
induces lung injury by involving angiotensin converting 
enzyme, by cell apoptosis induced by specific viral proteins, 
and by cytokine storm, the uncontrolled systemic inflam-
matory response resulting from the release of large amounts 
of pro- inflammatory cytokine and chemokines1 (Figure 1).
It has been reported that CT patterns of pulmonary viral 
infection are related to their pathogenesis and most viral 
pneumonia patterns exhibit similarity based on viridae.2 
Therefore, the imaging findings of coronavirus infection 
caused by SARS- CoV, MERS- CoV, and SARS- CoV-2 
closely resemble each other. The purpose of this pictorial 
review is to provide imaging spectrums of coronavirus 
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abStract:
During the first two decades of the 21st century, there have been three coronavirus infection outbreaks raising global 
health concerns by severe acute respiratory syndrome coronavirus (SARS- CoV), the Middle East respiratory syndrome 
coronavirus (MERS- CoV), and the SARS- CoV-2. Although the reported imaging findings of coronavirus infection are 
variable and non- specific, the most common initial chest radiograph (CXR) and CT findings are ground- glass opacities 
and consolidation with peripheral predominance and eventually spread to involve both lungs as the disease progresses. 
These findings can be explained by the immune pathogenesis of coronavirus infection causing diffuse alveolar damage. 
Although it is insensitive in mild or early coronavirus infection, the CXR remains as the first- line and the most commonly 
used imaging modality. That is because it is rapid and easily accessible and helpful for monitoring patient progress 
during treatment. CT is more sensitive to detect early parenchymal lung abnormalities and disease progression, and can 
provide an alternative diagnosis. In this pictorial review, various coronavirus infection cases are presented to provide 
imaging spectrums of coronavirus infection and present differences in imaging among them or from other viral infec-
tions, and to discuss the role of imaging in viral infection outbreaks.
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or from other viral infections, and discuss the role of imaging in 
viral infection outbreaks.
Epidemiology and clinical characteristics of human 
coronavirus infection
Table 1 presents the epidemiology and clinical characteristics of 
three outbreaks of coronavirus infection. Although the mortality 
rate of SARS- CoV-2 infection is the lowest among the three 
outbreaks, the number of confirmed cases of SARS- CoV-2 infec-
tion worldwide has exceeded 6,700,000, which is about 2,700 
times that of MERS- CoV infection. Males are more susceptible 
to MERS- CoV and SARS- CoV-2 infections. Up to half of the 
patients with coronavirus infection have comorbidities such as 
diabetes, hypertension, and cardiovascular disease and older 
age has been reported as an important predictor of increased 
mortality in coronavirus infection.3–5 Clinical and laboratory 
features of coronavirus infection by SARS- CoV, MERS- CoV, 
and SARS- CoV-2 have some similarities among them. Fever, 
Figure 1. Immune- pathogenesis of coronavirus infection. To 
enter into host cells, envelope spike glycoprotein of corona-
virus binds to the cellular receptor of host cells (1). After the 
virus enters the cells, the viral RNA genome is released and 
replicated (2). While the virus enters the cells, its antigen is 
presented to antigen- presenting cell such as dendritic cell or 
macrophage (3), which migrates to regional lymph nodes and 
stimulates the body’s humoral and cellular immunity by virus- 
specific B and T cells (4). Virus- specific B and T cells produce 
antibodies and release numerous cytokines. Cytokines induce 
the recruitment of neutrophils and monocyte- derived alveo-
lar macrophage, and these amplify the inflammatory response 
(5). The exuberant inflammatory response can disrupt the 
alveolar- capillary barrier, resulting in alveolar flooding and 
intra- alveolar fibrin accumulation (6). Cytokine storm, which 
is an uncontrolled systemic inflammatory response result-
ing from the release of a large amount of pro- inflammatory 
cytokines, causes acute respiratory distress syndrome and 
multiorgan failure. These immune responses result in diffuse 
alveolar damage or organizing pneumonia, which are man-
ifested as ground- glass opacity, consolidation, crazy paving 
appearance, and reversed halo sign with peripheral predomi-
nance on CT (7).












  Confirmed cases 8,422 2494 6,799,713*
  Death 916 858 397,388*
  Mortality rates % 11 34.4 5.8*
  Age (years) 44 56 51–56
  Sex ratio (male to 
female)
0.8:1 3.3:1 1.7:1
  Underlying diseases 
%
  Diabetes 24 36–66 11–19
  Hypertension 19 31–65 19–30
  Cardiovascular 
disease
10 20–41 4–8
  Malignancy 3 2 0.5–1
Symptoms %
  Fever 99–100 40–100 94
  Cough 62–100 29–100 79–81
  Dyspnea 40–42 48–100 40
  Myalgia 45–61 32 15–32
  Headache 20–56 13 10–14
  Sore throat 9–25 7–83 5–8
  Nausea or vomiting 20–35 21 4
  Diarrhea 20–32 26 5
Laboratory findings %
  Lymphopenia 65–89 34 40–65
  Increased CRP 78 63 52–86
  Thrombocytopenia 33–46 36 23–42
  LDH elevation 56–87 49 67–98
CRP, C- reactive protein; LDH, lactate dehydrogenase; MERS- CoV, 
Middle East respiratory syndrome coronavirus; SARS- CoV, severe 
acute respiratory syndrome coronavirus; SARS- CoV-2, severe acute 
respiratory syndrome coronavirus 2.
aSituation on June 07, 2020
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Table 2. Imaging findings of coronavirus infection
Characteristics SARS- CoV MERS- CoV SARS- CoV-2
Chest Radiograph
  Initial imaging
  Normal finding % 20 17 31
  Parenchymal abnormalities
  GGO + +++ +++
  Consolidation +++ + ++
  Nodule -/+ -/+ -
  Cavity - -/+ -
  Pleural effusion + ++ -/+
  Pneumothorax - + -
  Distribution
  Transverse Peripheral Peripheral Peripheral
  Longitudinal Lower lung Middle & lower lung Lower lung/random
  Laterality Unilateral Unilateral Bilateral
  Follow- up imaging with progression Entire bilateral lung Entire bilateral lung Entire bilateral lung
  Prognostic determinant CXR score CXR score, pleural effusion, pneumothorax CXR score
Chest tomography
  Initial imaging
  Parenchymal abnormalities
  GGO +++ +++ ++++
  Consolidation ++ ++ ++
  Mixed GGO & consolidation ++ ++ ++
  Intralobular interstitial thickening ++ + ++
  Interlobular septal thickening ++ ++ ++
  Crazy paving appearance ++ + +
  Reticulation - - -
  Traction bronchiectasis - - -
  Large nodule - - -
  Centrilobular nodule - -/+ -
  Cavity - - -
  Pleural effusion + ++ -
  Pneumothorax - - -
  Hilar or mediastinal LN enlargement - - -
  Distribution Peripheral, lower lung Peripheral, lower lung Peripheral, random
  Laterality Unilateral Unilateral Bilateral
  Follow- up imaging after 4 weeks
  Predominant findings Signs of fibrosis Signs of fibrosis Signs of fibrosis
  Prognostic determinant CT score CT score, pleural effusion CT score
SARS- CoV = severe acute respiratory syndrome coronavirus, MERS- CoV = Middle East respiratory syndrome coronavirus, SARS- CoV-2=severe 
acute respiratory syndrome coronavirus 2,
aextent of each parenchymal abnormality <25%, ++;≥25%,<50%, +++;≥50%,<75%, ++++;≥75%, GGO = ground- glass opacity, CXR = chest radiograph, 
LN = lymph node
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cough, and dyspnea are the major symptoms in those admitted 
to the hospital. Gastrointestinal symptoms such as vomiting or 
diarrhea are relatively rare in SARS- CoV-2 infection, compared 
to 20–26% of patients with SARS- CoV or MERS- CoV infection 
having gastrointestinal symptoms.3,4 In terms of laboratory find-
ings, a significant number of patients have lymphocytopenia in 
coronavirus infection, indicating the consumption of immune 
cells and resultant impairment of cellular immunity.3,4
Imaging findings of coronavirus infection
Initial and follow-up chest radiographs (CXR) 
findings
Table 2 summarizes imaging findings of coronavirus infection. 
Approximately 15%–20% of patients with coronavirus infec-
tion have normal initial CXR.6–8 The most common initial CXR 
findings of coronavirus infection are peripheral focal or multi-
focal airspace consolidation, ground- glass opacities (GGO), or 
both6–8 (Figures  2–5). However, initial imaging in SARS- CoV 
(Figures 2–4) and MERS- CoV infections (Figures 2 and 5) usually 
shows unilateral and middle- to- lower lung zone involvement of 
parenchymal lesions, whereas bilateral lung involvements with 
lower lung zone or no zonal predominance are more common 
in SARS- CoV-2 infection6–8 (Figure  2). Cavity and nodular 
opacity are rare in coronavirus infection. Pleural effusion is rare 
in SARS- CoV-2 infection, but it occurs approximately 15 and 
30% of SARS- CoV and MERS- CoV infections during first week 
of infection6,7 (Figure 6). As the disease progresses, parenchymal 
abnormalities eventually spread to involve the lungs bilaterally in 
coronavirus infection (Figures 3–7).
Initial and follow-up chest CT findings
Similar to the CXR findings of coronavirus infection, the CT 
findings include GGO with or without interlobular septal 
Figure 2. Initial imaging presentation of coronavirus infection. 
(a) Initial chest radiograph (CXR) obtained from a 52- year- old 
male patient with SARS- CoV infection shows a focal nodu-
lar opacity in the peripheral area of right middle lung zone. 
(b) Initial CT scan obtained from a 47- year- old female patient 
with SARS- CoV infection shows focal area of ground- glass 
opacity (GGO) with crazy paving appearance in the periph-
eral portion of right lower lobe. (c, d) Initial CXR and CT scan 
obtained from a 36- year- old male patient with MERS- CoV 
infection show multifocal patchy consolidation in left middle 
to lower lung zones on CXR (c) and focal airspace consolida-
tion with air- bronchogram, ill- defined nodules, and peripheral 
GGOs on CT scan (d). (e, f) Initial CXR and CT scan obtained 
from a 73- year- old male patient with SARS- CoV-2 infection 
show bilateral multifocal GGOs on CXR (e) and patchy areas 
of GGO with crazy paving appearance with peripheral pre-
dominance on CT scan (f).
Figure 3. A 36- year- old male patient with SARS- CoV infec-
tion. (a) Initial chest radiograph (CXR) shows focal nodular 
consolidation in left upper lung zone. (b) Follow- up CXR 
obtained 6 days after (a) shows rapid progression with bilat-
eral diffuse consolidation and GGOs.
Figure 4. A 31- year- old male with SARS- CoV infection. (a) Ini-
tial chest radiograph (CXR) obtained on the day of admission 
shows unilateral lobar consolidation in left lung. (b) Follow- up 
CXR obtained 4 days after (a) shows rapid progression with 
bilateral diffuse ground- glass opacities (GGOs) and consolida-
tion. (c) Follow- up chest CT obtained 40 days after admission 
shows bilateral diffuse GGOs with superimposed intralobular 
interstitial thickenings and reticulation, suggesting pulmonary 
fibrosis.
Figure 5. A 60- year- old male patient with MERS- CoV infec-
tion. (a) Chest radiograph (CXR) obtained on 8 days after 
exposure shows consolidation and GGOs in right upper lung 
zone. (b) Follow- up CXR obtained 18 days after exposure 
shows multifocal consolidations in both lungs. (c) Follow- up 
chest CT obtained on the same day with (b) shows bilateral, 
multifocal, mixed consolidation and GGOs with crazy paving 
appearance, suggesting organizing pneumonia.
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thickening, consolidation, or a combination of both; these are 
the most common findings during the first two weeks of coro-
navirus infection9–11 (Figures 2 and 8–10). In SARS- CoV infec-
tion, reticulation is evident after the second week of infection 
and persists in half of the patients after 4 weeks9 (Figure 4). In 
MERS- CoV infection, crazy paving abnormalities and orga-
nizing pneumonia (OP) are seen during the second and third 
weeks of infection10 (Figure 5). In SARS- CoV-2 infection, GGO 
(with or without crazy paving appearance) and consolidation 
show a decrease in extents, whereas a mixed pattern of GGO 
and consolidation demonstrates an increase after second week of 
infection11 (Figure 11). Cavity, centrilobular nodules (Figure 12), 
mediastinal, or hilar lymph node enlargement are rarely seen in 
coronavirus infection. Pulmonary vascular enlargements in areas 
of lung opacity can be seen in more than half of the patients with 
SARS- CoV-2 infection12 and venous or arterial thromboembolic 
disease may be complicated in about 30% of critically ill patients 
with SARS- CoV-2 infection due to excessive vascular inflamma-
tion or diffuse intravascular coagulation13 (Figures 13 and 14).
The location and distribution of parenchymal abnormalities 
and disease progression patterns are similar to those seen on 
CXRs.9–11,14 During the early stage of the disease, parenchymal 
abnormalities are usually located in the peripheral lung; from 
there, they eventually spread to involve both lungs when the 
disease progresses (Figure  10). Parenchymal abnormalities 
usually have a peripheral and basilar predilection in MERS- CoV 
infection10 (Figures  2 and 5), whereas with peripheral or both 
peripheral and central predilection bilateral multilobe lesions 
are seen in SARS- CoV-2 infection11,14 (Figures 2, 9–11, 13 and 
14). In the chronic stage of coronavirus infection, variable- sized 
GGO with interlobular septal and intralobular interstitial thick-
enings are the most common findings. Signs of fibrosis such as 
parenchymal bands, reticulation, traction bronchiectasis, irreg-
ular interface signs are also usually seen9–11 (Figures 4, 9, 13 and 
15). In SARS- CoV infection, GGO and interstitial opacity in the 
Figure 6. A 68- year- old male with MERS- CoV infection. (a) 
Initial chest radiograph (CXR) obtained 1 day after symp-
tom onset shows ill- defined patchy ground- glass opacities 
(GGOs) in both middle to lower lung zones. (b) Follow- up 
CXR obtained 14 days after symptom onset shows rapid pro-
gression with bilateral diffuse GGOs and consolidation in both 
lungs. Also note blunting of left costophrenic angle, suggest-
ing pleural effusion. (c) Follow- up chest CT obtained 18 days 
after symptom onset shows bilateral consolidation and GGOs 
with bilateral pleural effusion. He died of respiratory failure.
Figure 7. A 36- year- old male patient with MERS- CoV infec-
tion. He had a contact history of MERS patients and suffered 
from fever. (a) Initial chest radiograph (CXR) shows multifocal 
patchy consolidation in left middle to lower lung zones. (b) 
Follow- up CXR obtained 15 days after (a) shows increased 
extents of multifocal patchy consolidation in left middle to 
lower lung zones and new appearance of diffuse ground- glass 
opacities and consolidation in the peripheral portion of right 
lung. (c) Follow- up CXR obtained 18 days after (a) shows 
bilateral diffuse consolidation, suggesting acute respiratory 
distress syndrome.
Figure 8. A 68- year- old male patient with MERS- CoV infec-
tion. He had a history of visiting Bahrain and suffered from 
fever, myalgia, and dry cough. (a, b) Axial and coronal images 
of chest CT scan obtained 4 days after symptom onset show 
mixed consolidation and ground- glass opacity with the crazy 
paving appearance in right upper lobe.
Figure 9. A 64- year- old male patient with SARS- CoV-2 infec-
tion. (a) Initial chest radiograph (CXR) obtained 7 days after 
symptom onset shows bilateral multifocal patchy ground- 
glass opacities (GGOs) with peripheral predominance. (b, 
c) Chest CT scans obtained on the same day with (a) show 
multifocal patchy and diffuse GGOs with the crazy paving 
appearance and mixed GGO and consolidation in both lungs. 
(d) Follow- up CXR after 2 days of (a) shows rapid progres-
sion with bilateral diffuse consolidations and GGOs. (e, f) Fol-
low- up chest CT scans obtained 1 month later show markedly 
decreased extent of GGO with remnant subpleural line and 
traction bronchiectasis, suggesting pulmonary fibrosis.
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convalescent phase usually resolve over time but air trapping 
may persist.15
Prognostic determinants
Several studies have been conducted to investigate the correla-
tion between imaging findings and clinical outcomes. Higher 
CT and CXR scores (percentage of lungs or the number of zones 
involved with opacification), especially in patients with old age and 
comorbid lung illness, could be used as fatal prognostic indicators 
in SARS- CoV infection.5 In MERS- CoV infection, a greater extent 
of parenchymal abnormalities, pleural effusion, and pneumothorax 
was associated with poor prognosis and short- term mortality 
(Figure 6).10,16 Although imaging features that help determine the 
prognosis of SARS- CoV-2 infection are not yet fully understood, 
older age and progressive consolidation with a greater extent on 
imaging might suggest poorer prognosis (Figure 10).
Differential diagnosis
Coronavirus infection is sometimes difficult to distinguish from 
other viral infections, bacterial pneumonia, or OP associated with 
other causes. Viral pneumonia in an immunocompetent patient 
can be divided into bronchopneumonia, OP, and diffuse alveolar 
damage (DAD) pattern. OP and DAD pattern are common features 
of coronavirus pneumonia and can be seen during the disease 
course or in advanced disease. Viral pneumonia showing OP or 
Figure 10. A 78- year- old male patient with SARS- CoV-2 infec-
tion. He had a history of exposure to an infected patient and 
had fever and myalgia for 1 day. (a, b) Initial chest CT scans 
obtained 2 days after symptom onset show focal subpleu-
ral ground- glass opacity (GGO) in left lower lobe. (c, d) Fol-
low- up CT scans obtained 7 days after symptom onset show 
increased extent of GGO in left lower lobe and new appear-
ance of multifocal subpleural patchy GGOs with the crazy 
paving appearance in both lungs. (e) Follow- up chest radio-
graph obtained 15 days after symptom onset shows bilateral 
diffuse GGOs and consolidation in both lungs, suggesting dif-
fuse alveolar damage. He died of respiratory failure.
Figure 11. A 64- year- old female patient with SARS- CoV-2 
infection. (a) Initial chest radiograph shows faint ground- glass 
opacities (GGOs) in both lower lung zones. (b, c) Follow- up 
CT scans obtained 14 days after symptom onset show mixed 
GGOs and consolidation in both lower lung lobes.
Figure 12. A 43- year- old male with SARS- CoV infection. Chest 
CT obtained 25 days after symptom onset shows bilateral dif-
fuse ill- defined centrilobular and ground- glass opacity nod-
ules in both lungs. Also, note focal consolidation in right lower 
lobe.
Figure 13. A 78- year- old female patient with SARS- CoV-2 
infection. (a) Initial chest radiograph shows bilateral dif-
fuse consolidation in both lungs. (b) Lung window image of 
contrast- enhanced chest CT scan obtained on the same day 
with (a) shows mixed ground- glass opacities (GGOs) and con-
solidation in both lungs. (c, d) Mediastinal window images of 
contrast- enhanced chest CT scan obtained on the same day 
with (a) show thromboembolism (arrow) involving right inter-
lobar pulmonary artery and irregular- walled vessels (arrow-
head) toward consolidation in right lower lobe. (e) Follow- up 
chest CT scan after 1 month of (a) shows decreased extent 
of mixed GGOs and consolidation with remnant multifocal 
patchy GGOs, parenchymal bands, traction bronchiectasis, 
and irregular interface, suggesting pulmonary fibrosis.
7 of 8 birpublications.org/bjr Br J Radiol;93:20200515
BJRImaging Findings of Coronavirus Infections
DAD patterns include influenza virus, Hantavirus, adenovirus, 
and varicella- zoster virus pneumonia. Consolidation and GGO 
with subpleural or peribronchovascular predominance are typical 
imaging findings of OP. Therefore, cryptogenic OP and OP associ-
ated with infection, drug, and collagen vascular disease should be 
considered to be differentiated from coronavirus infection.
It is difficult to differentiate coronavirus infection from other 
diseases by imaging alone; therefore, clinical manifestation, 
contact history, and laboratory tests should also be considered to 
make the final diagnosis.
Role of imaging in coronavirus infection
The main role of imaging in viral infection outbreak is to identify 
the presence of pneumonia, provide differential diagnosis, and 
monitor changes of pneumonia with treatment. When deciding 
which imaging modality to use for establishing a diagnosis or for 
guiding management in viral infection outbreak, there are several 
factors to consider; patient’s clinical severity, radiation hazard to 
the patient, accessibility of imaging modalities, possibility of virus 
transmission to uninfected healthcare workers and other patients, 
and community infection status.17
Although it is insensitive in mild or early coronavirus infec-
tion, CXR remains the first- line and the most commonly used 
imaging modality because it is rapid and easily accessible. It is 
also helpful for monitoring patient progress during treatment. 
CT is more sensitive to detect early parenchymal lung abnor-
malities and disease progression, and can provide an alterna-
tive diagnosis. However, CT lacks equipment portability with 
imaging performed within an infected patient’s isolation room 
and has a risk of virus transmission along the transport route 
to a CT scanner and within the CT room. CT can be used when 
the patient has symptoms but the CXR is normal or there are 
only questionable abnormalities on CXR. CT is also indicated 
in patients with functional impairment and/or hypoxemia after 
recovery from coronavirus infection. Contrast- enhanced CT 
may be indicated in patients with signs of thrombotic compli-
cation. The appropriate use of imaging in each clinical situation 
should be considered on this basis.17
concluSionS
Although imaging findings of coronavirus infection are non- 
specific and have significant overlap among those of SARS- CoV, 
MERS- CoV, and SARS- CoV-2 infections, they have several 
important differences. The most common initial CXR and CT 
findings are GGO and consolidation with peripheral predomi-
nance and these lesions eventually spread to involve both lungs 
as the disease progresses and pulmonary fibrosis may develop 
after long- term follow- up. Imaging features that help determine 
the clinical outcome or prognosis of coronavirus infection are 
the extents of parenchymal abnormalities. The greater extents 
of parenchymal abnormalities, especially in patients with old 
age or comorbidity, might suggest poorer prognosis in corona-
virus infection, necessitating intensive care unit management, or 
predicting oncoming succumbing to death.
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Figure 14. A 71- year- old male patient with SARS- CoV-2 infec-
tion. (a) Initial chest radiograph shows bilateral peripheral 
ground- glass opacities (GGOs) and multifocal patchy con-
solidation in both lungs. (b) Lung window image of contrast- 
enhanced chest CT scan obtained on the same day with (a) 
shows consolidation and patchy GGOs in the subpleural areas 
of both lower lobes. (c) Mediastinal window image of contrast- 
enhanced chest CT scan obtained on the same day with (a) 
shows thromboembolism (arrow) involving right lower lobar 
pulmonary artery.
Figure 15. A 32- year- old male with MERS- CoV infection. (a) 
Chest radiograph (CXR) obtained on 15 days after symptom 
onset shows consolidation and ground- glass opacities in both 
middle to lower lung zones. (b) Follow- up CXR obtained 50 
days after symptom onset shows linear and patchy opaci-
ties in both lower lung zones, which may represent fibrosing 
sequelae. (c, d) Follow- up chest CT scans obtained on the 
same day with (b) show parenchymal bands, linear opacities, 
and traction bronchiectasis in both lower lobes, suggesting 
remnant fibrosis.
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